| Schedule of Computation of Net Loss Per Common Share |
The following table sets forth the computation of net loss per common share: | | | | | | | | | | | | | | | | | | | (dollar amounts in thousands) | Fiscal Year Ended December 31, 2023 | | Fiscal Year Ended December 25, 2022 | | Fiscal Year Ended December 26, 2021 | Numerator: | | | | | | Net loss | $ | (113,384) | | | $ | (190,441) | | | $ | (153,175) | | Denominator: | | | | | | Weighted-average common shares outstanding—basic and diluted | 111,907,675 | | | 110,128,287 | | | 27,782,442 | | Earnings per share—basic and diluted | $ | (1.01) | | | $ | (1.73) | | | $ | (5.51) | |
|
| Schedule of Anti-dilutive Shares Excluded |
The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect: | | | | | | | | | | | | | | | | | | | | Fiscal Year Ended December 31, 2023 | | Fiscal Year Ended December 25, 2022 | | Fiscal Year Ended December 26, 2021 | | Options to purchase common stock | 13,219,388 | | | 13,813,922 | | | 13,773,414 | | | Time-based vesting restricted stock units | 951,517 | | | 1,780,681 | | | 2,392,426 | | | Performance stock units | 6,621,428 | | | 6,621,428 | | | 6,621,428 | | | Contingently issuable stock | 714,285 | | | 714,285 | | | 714,285 | | Total common stock equivalents | 21,506,618 | | | 22,930,316 | | | 23,501,553 | |
|